Immatics (IMTX) Shares Outstanding (Diluted Average) (2021 - 2025)

Immatics' (IMTX) quarterly Shares Outstanding (Diluted Average) came in at $1030.1 in Q2 2025, down 100.0% year-on-year from $111.0 million in Q2 2024, and up 588.54% quarter-over-quarter from $149.6 in Q4 2024.

Immatics (IMTX) Shares Outstanding (Diluted Average) (2021 - 2025) Analysis & Trends

Immatics has disclosed Shares Outstanding (Diluted Average) across 5 years of filings, most recently posting $1030.1 for Q2 2025.

  • Shares Outstanding (Diluted Average) for Q2 2025 came in at $1030.1, down 100.0% year-over-year; the trailing twelve-month figure through Jun 2025 was $1030.1 (down 100.0% YoY), and the FY2024 annual result was $149.6, down 100.0% from the prior year.
  • Shares Outstanding (Diluted Average) came in at $1030.1 for Q2 2025 at Immatics, up from $149.6 in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $111.0 million in Q2 2024 to a low of $10.86 in Q1 2024.
  • The 5-year median for Shares Outstanding (Diluted Average) is $1349.8 (2022), against an average of $31.0 million.
  • Across the five-year window, Shares Outstanding (Diluted Average) jumped 11542056.9% in 2023 and sank 100.0% in 2024, its largest moves.
  • Immatics' Shares Outstanding (Diluted Average) stood at $74.2 million in 2021, then fell by 5.35% to $70.2 million in 2022, then increased by 23.42% to $86.7 million in 2023, then slumped by 100.0% to $149.6 in 2024, then jumped by 588.54% to $1030.1 in 2025.
  • The last three Shares Outstanding (Diluted Average) figures came in at $1030.1 (Q2 2025), $149.6 (Q4 2024), and $43.93 (Q3 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4,489.46 Bn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 810.00
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 118.76 Bn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 1.48 Bn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 256.30 Mn
9 Abivax 91.96 Bn 91.96 Bn - 92.44 Mn
10 Immatics 14.67 Bn 14.67 Bn - -

Historic Data

Download Data
DateValue
Jun 30, 2025 1,030.08
Dec 31, 2024 149.60
Sep 30, 2024 43.93
Jun 30, 2024 111.00 Mn
Mar 31, 2024 10.86
Dec 31, 2023 86.66 Mn
Sep 30, 2023 90.77 Mn
Jun 30, 2023 631,576.15
Dec 31, 2022 70.22 Mn
Sep 30, 2022 786.45
Jun 30, 2022 1,184.43
Mar 31, 2022 1,515.16
Sep 30, 2021 74.19 Mn
Jun 30, 2021 939.33